The Chinese Glioma Cooperative Group (CGCG) Guideline Panel for adult diffuse gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel covered all fields of expertise in neurooncology, i.e. neurosurgeons, neurologists, neuropathologists, neuroradiologists, radiation and medical oncologists and clinical trial experts. The task made clearer and more transparent choices about outcomes considered most relevant through searching the references considered most relevant and evaluating their value. The scientific evidence of papers collected from the literature was evaluated and graded based on the Oxford Centre for Evidence-based Medicine Levels of Evidence and recommendations were given accordingly. The recommendations will provide a framework and assurance for the strategy of diagnostic and therapeutic measures to reduce complications from unnecessary treatment and cost. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also as a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China. (C) 2016 The Authors. Published by Elsevier Ireland Ltd.
基金：
Research Special Fund For Public Welfare Industry of Heath [201402008]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03, 2014BAI04B02]; National High Technology Research and Development Program (863) [2012AA02A508]; Beijing Science and Technology Plan [Z131100006113018]; National Natural Science Foundation of China [91229121, 81201993, 81572701, 81372700]; International Science and Technology Cooperation Program [2012DFA30470]
语种：
外文
高被引：
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2015]版：
大类|2 区医学
小类|2 区肿瘤学
最新[2023]版：
大类|1 区医学
小类|2 区肿瘤学
第一作者：
第一作者机构：[1]Beijing Neurosurg Inst, Beijing 100050, Peoples R China;[2]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing 100069, Peoples R China;[4]China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China;
通讯作者：
通讯机构：[1]Beijing Neurosurg Inst, Beijing 100050, Peoples R China;[2]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing 100069, Peoples R China;[4]China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China;[5]Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China;[6]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China;[7]Peking Union Med Coll, Beijing 100730, Peoples R China;[8]Sichuan Univ, West China Med Sch, West China Hosp, Dept Neurosurg, Chengdu 610041, Peoples R China;[9]Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China;
推荐引用方式(GB/T 7714)：
Jiang Tao,Mao Ying,Ma Wenbin,et al.CGCG clinical practice guidelines for the management of adult diffuse gliomas[J].CANCER LETTERS.2016,375(2):263-273.doi:10.1016/j.canlet.2016.01.024.
APA：
Jiang, Tao,Mao, Ying,Ma, Wenbin,Mao, Qing,You, Yongping...&Wang, Qixue.(2016).CGCG clinical practice guidelines for the management of adult diffuse gliomas.CANCER LETTERS,375,(2)
MLA：
Jiang, Tao,et al."CGCG clinical practice guidelines for the management of adult diffuse gliomas".CANCER LETTERS 375..2(2016):263-273
医学